IVF Services Market By Type (Fresh IVF Cycle, Thawed IVF Cycle, Donor Egg IVF Cycle) , By End User (Fertility Clinics, Hospitals, Surgical Centers, Clinical Research Institutes) : Global Opportunity Analysis and Industry Forecast, 2024-2033

Description

The IVF services market was valued at $19.6 billion in 2023, and is projected to reach $47.9 billion by 2033, growing at a CAGR of 9.3% from 2024 to 2033.

In vitro fertilization (IVF), also called as assisted reproductive technology, serves as the most effective type of fertility treatment that involves administration of medication to promote follicle growth. During the procedure, eggs are retrieved from the ovaries and fertilized with sperm in a laboratory. The fertilized eggs (embryos) are then transferred to the uterus.

The growth of the global IVF services market is driven by alarming rise in infertility cases due to increase in trend of delayed parenthood and desire to prioritize career pursuits. According to a study published by Cleveland Clinic, an American nonprofit academic medical center, infertility affects 186 million people worldwide, and the male partner is the cause in about 50% of the cases. Some studies reveal that male infertility affects about 10-15% of males in the U.S. Moreover, surge in prevalence of conditions such as fallopian tube damage or blockage, ovulation disorders, endometriosis, uterine fibroids, previous surgery to prevent pregnancy, issues with sperms, unexplained infertility, or genetic disorders boost the demand for IVF services. Furthermore, increase in government initiatives to address infertility issues notably contributes toward the market growth. For instance, the , the Centers for Disease Control and Prevention (CDC) developed the National Public Health Action Plan for the Detection, Prevention, and Management of Infertility in June 2014. This plan emphasizes the need to better understand and address issues that contribute to and are caused by infertility in women and men and that may affect the health of the pregnancy. However, high costs associated with the treatment and limited insurance coverage act as the key deterrent factors of the global market. On the contrary, technological advancements and improving healthcare infrastructure are expected to offer remunerative opportunities for the expansion of the global market during the forecast period. Moreover, increase in trend of fertility tourism allows patients choose IVF treatment overseas for more affordable options or access to cutting-edge methods, which is expected to open new avenues for the market growth in the coming years.

The IVF services industry is segmented into cycle type, end user, and region. On the basis of cycle type, the market is divided into fresh IVF cycle, Thawed IVF cycle, and donor egg IVF cycle. By end user, the market is divided into fertility clinics, hospitals, surgical centers, and clinical research institutes. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

Depending on cycle type, the fresh IVF cycles segment accounted for the largest share in 2023 in IVF services market.

On the basis of end user, the fertility clinics segment was the major shareholder in 2023.

Region wise, North America was the major revenue contributor in 2023 and is expected to dominate the market during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global IVF services market include Mayo Clinic Fertility Center, Shady Grove Fertility Center, Reproductive Medicine Associates, Boston IVF, LLC., Colorado Center for Reproductive Medicine, pacific fertility center, Houston Fertility Institute, Columbia University Fertility Center, Cleveland Clinic Fertility Center, and Fertility Centers of Illinois. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

Additional company profiles with specific to client's interest

Key Market Segments

By Type

Fresh IVF Cycle
Thawed IVF Cycle
Donor Egg IVF Cycle

By End User

Fertility Clinics
Hospitals
Surgical Centers
Clinical Research Institutes

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA

Key Market Players:

Mayo Clinic Fertility Center
Shady Grove Fertility Center
Reproductive Medicine Associates
Boston IVF, LLC.
Colorado Center for Reproductive Medicine
pacific fertility center
Houston Fertility Institute
Columbia University Fertility Center
Cleveland Clinic Fertility Center
Fertility Centers of Illinois

Product Code: A00556

CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope
3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities

CHAPTER 4: IVF SERVICES MARKET, BY TYPE

4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Type
4.2. Fresh IVF Cycle
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
4.3. Thawed IVF Cycle
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
4.4. Donor Egg IVF Cycle
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country

CHAPTER 5: IVF SERVICES MARKET, BY END USER

5.1. Market Overview
- 5.1.1 Market Size and Forecast, By End User
5.2. Fertility Clinics
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
5.3. Hospitals
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
5.4. Surgical Centers
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
5.5. Clinical Research Institutes
- 5.5.1. Key Market Trends, Growth Factors and Opportunities
- 5.5.2. Market Size and Forecast, By Region
- 5.5.3. Market Share Analysis, By Country

CHAPTER 6: IVF SERVICES MARKET, BY REGION

6.1. Market Overview
- 6.1.1 Market Size and Forecast, By Region
6.2. North America
- 6.2.1. Key Market Trends and Opportunities
- 6.2.2. Market Size and Forecast, By Type
- 6.2.3. Market Size and Forecast, By End User
- 6.2.4. Market Size and Forecast, By Country
- 6.2.5. U.S. IVF Services Market
  - 6.2.5.1. Market Size and Forecast, By Type
  - 6.2.5.2. Market Size and Forecast, By End User
- 6.2.6. Canada IVF Services Market
  - 6.2.6.1. Market Size and Forecast, By Type
  - 6.2.6.2. Market Size and Forecast, By End User
- 6.2.7. Mexico IVF Services Market
  - 6.2.7.1. Market Size and Forecast, By Type
  - 6.2.7.2. Market Size and Forecast, By End User
6.3. Europe
- 6.3.1. Key Market Trends and Opportunities
- 6.3.2. Market Size and Forecast, By Type
- 6.3.3. Market Size and Forecast, By End User
- 6.3.4. Market Size and Forecast, By Country
- 6.3.5. France IVF Services Market
  - 6.3.5.1. Market Size and Forecast, By Type
  - 6.3.5.2. Market Size and Forecast, By End User
- 6.3.6. Germany IVF Services Market
  - 6.3.6.1. Market Size and Forecast, By Type
  - 6.3.6.2. Market Size and Forecast, By End User
- 6.3.7. Italy IVF Services Market
  - 6.3.7.1. Market Size and Forecast, By Type
  - 6.3.7.2. Market Size and Forecast, By End User
- 6.3.8. Spain IVF Services Market
  - 6.3.8.1. Market Size and Forecast, By Type
  - 6.3.8.2. Market Size and Forecast, By End User
- 6.3.9. UK IVF Services Market
  - 6.3.9.1. Market Size and Forecast, By Type
  - 6.3.9.2. Market Size and Forecast, By End User
- 6.3.10. Rest of Europe IVF Services Market
  - 6.3.10.1. Market Size and Forecast, By Type
  - 6.3.10.2. Market Size and Forecast, By End User
6.4. Asia-Pacific
- 6.4.1. Key Market Trends and Opportunities
- 6.4.2. Market Size and Forecast, By Type
- 6.4.3. Market Size and Forecast, By End User
- 6.4.4. Market Size and Forecast, By Country
- 6.4.5. China IVF Services Market
  - 6.4.5.1. Market Size and Forecast, By Type
  - 6.4.5.2. Market Size and Forecast, By End User
- 6.4.6. Japan IVF Services Market
  - 6.4.6.1. Market Size and Forecast, By Type
  - 6.4.6.2. Market Size and Forecast, By End User
- 6.4.7. India IVF Services Market
  - 6.4.7.1. Market Size and Forecast, By Type
  - 6.4.7.2. Market Size and Forecast, By End User
- 6.4.8. South Korea IVF Services Market
  - 6.4.8.1. Market Size and Forecast, By Type
  - 6.4.8.2. Market Size and Forecast, By End User
- 6.4.9. Australia IVF Services Market
  - 6.4.9.1. Market Size and Forecast, By Type
  - 6.4.9.2. Market Size and Forecast, By End User
- 6.4.10. Rest of Asia-Pacific IVF Services Market
  - 6.4.10.1. Market Size and Forecast, By Type
  - 6.4.10.2. Market Size and Forecast, By End User
6.5. LAMEA
- 6.5.1. Key Market Trends and Opportunities
- 6.5.2. Market Size and Forecast, By Type
- 6.5.3. Market Size and Forecast, By End User
- 6.5.4. Market Size and Forecast, By Country
- 6.5.5. Brazil IVF Services Market
  - 6.5.5.1. Market Size and Forecast, By Type
  - 6.5.5.2. Market Size and Forecast, By End User
- 6.5.6. South Africa IVF Services Market
  - 6.5.6.1. Market Size and Forecast, By Type
  - 6.5.6.2. Market Size and Forecast, By End User
- 6.5.7. Saudi Arabia IVF Services Market
  - 6.5.7.1. Market Size and Forecast, By Type
  - 6.5.7.2. Market Size and Forecast, By End User
- 6.5.8. Rest of LAMEA IVF Services Market
  - 6.5.8.1. Market Size and Forecast, By Type
  - 6.5.8.2. Market Size and Forecast, By End User

CHAPTER 7: COMPETITIVE LANDSCAPE

7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

8.1. Mayo Clinic Fertility Center
- 8.1.1. Company Overview
- 8.1.2. Key Executives
- 8.1.3. Company Snapshot
- 8.1.4. Operating Business Segments
- 8.1.5. Product Portfolio
- 8.1.6. Business Performance
- 8.1.7. Key Strategic Moves and Developments
8.2. Shady Grove Fertility Center
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Operating Business Segments
- 8.2.5. Product Portfolio
- 8.2.6. Business Performance
- 8.2.7. Key Strategic Moves and Developments
8.3. Reproductive Medicine Associates
- 8.3.1. Company Overview
- 8.3.2. Key Executives
- 8.3.3. Company Snapshot
- 8.3.4. Operating Business Segments
- 8.3.5. Product Portfolio
- 8.3.6. Business Performance
- 8.3.7. Key Strategic Moves and Developments
8.4. Boston IVF, LLC.
- 8.4.1. Company Overview
- 8.4.2. Key Executives
- 8.4.3. Company Snapshot
- 8.4.4. Operating Business Segments
- 8.4.5. Product Portfolio
- 8.4.6. Business Performance
- 8.4.7. Key Strategic Moves and Developments
8.5. Colorado Center For Reproductive Medicine
- 8.5.1. Company Overview
- 8.5.2. Key Executives
- 8.5.3. Company Snapshot
- 8.5.4. Operating Business Segments
- 8.5.5. Product Portfolio
- 8.5.6. Business Performance
- 8.5.7. Key Strategic Moves and Developments
8.6. Pacific Fertility Center
- 8.6.1. Company Overview
- 8.6.2. Key Executives
- 8.6.3. Company Snapshot
- 8.6.4. Operating Business Segments
- 8.6.5. Product Portfolio
- 8.6.6. Business Performance
- 8.6.7. Key Strategic Moves and Developments
8.7. Houston Fertility Institute
- 8.7.1. Company Overview
- 8.7.2. Key Executives
- 8.7.3. Company Snapshot
- 8.7.4. Operating Business Segments
- 8.7.5. Product Portfolio
- 8.7.6. Business Performance
- 8.7.7. Key Strategic Moves and Developments
8.8. Columbia University Fertility Center
- 8.8.1. Company Overview
- 8.8.2. Key Executives
- 8.8.3. Company Snapshot
- 8.8.4. Operating Business Segments
- 8.8.5. Product Portfolio
- 8.8.6. Business Performance
- 8.8.7. Key Strategic Moves and Developments
8.9. Cleveland Clinic Fertility Center
- 8.9.1. Company Overview
- 8.9.2. Key Executives
- 8.9.3. Company Snapshot
- 8.9.4. Operating Business Segments
- 8.9.5. Product Portfolio
- 8.9.6. Business Performance
- 8.9.7. Key Strategic Moves and Developments
8.10. Fertility Centers of Illinois
- 8.10.1. Company Overview
- 8.10.2. Key Executives
- 8.10.3. Company Snapshot
- 8.10.4. Operating Business Segments
- 8.10.5. Product Portfolio
- 8.10.6. Business Performance
- 8.10.7. Key Strategic Moves and Developments